3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
19
Neoplasms
11
Polycystic Ovary Syndrome
9
Neoplasm Metastasis
4
Multiple Myeloma
4
Melanoma
4
Vomiting
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Obesity
2
Nausea
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Insulin Resistance
2
Inflammation
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Interventions
Cinacalcet
3
belinostat
2
Trastuzumab
2
Nivolumab
2
Denosumab
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
lutetium Lu 177 dotatate
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
fluorocholine
1
evocalcet
1
entinostat
1
acetaminophen, codeine drug combination
1
Tramadol
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sodium Chloride
1
Ritonavir
1
Radiotherapy
1
Parathyroidectomy
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Indinavir
1
Gefitinib
1
Fluorouracil
1
Dacarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Parathyroid Neoplasms
×
Tablets
×
Clear all
NCT03027557
2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3
Completed
46 enrolled
49 charts